StonvexLoading…
StonvexStonvexStonvexCore line items from LGVN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 |
|---|---|---|---|
Revenue | $1.20M | $2.39M | $709.00K |
Operating Income | $-23.29M | $-16.52M | $-21.03M |
Net Income | $-22.70M | $-15.97M | $-21.41M |
EPS (Diluted) | $-1.29 | $-2.62 | $-10.22 |
Total Assets | $10.26M | $25.56M | $12.08M |
Total Liabilities | $4.59M | $3.67M | $5.34M |
Cash & Equivalents | $4.66M | $19.23M | $4.95M |
Free Cash Flow OCF − CapEx | $-18.89M | $-14.52M | $-19.30M |
Shares Outstanding | 17.58B | 9.41B | 2.17B |